Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
about
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionExpression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremiaPathogenesis of human immunodeficiency virus infectionSelective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1Infection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-1.Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotypeCD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization.Transepithelial transport of HIV-1 by M cells is receptor-mediated.Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usageHuman immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replicationPathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu miceR5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expressionDistinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.Host genetic determinants of human immunodeficiency virus infection and disease progression in children.A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surfaceDifferential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family.V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virusPhenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.HIV-1 Transmission, Replication Fitness and Disease Progression.Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsyThe cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmissionIn vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitroCathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infectionVariants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropismShift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses.Antigenically distinct conformations of CXCR4.Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone.Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.
P2860
Q22241902-D6D021C2-7C9C-4441-A59A-01C8E812146EQ24529578-B03C44F7-8C5D-4A72-89E0-018477A4C60CQ24557545-15F2E01C-B617-49B6-9CA4-8E99CAB65A51Q24634681-2B32C1E6-4105-4587-9F6F-C2C634BD6A38Q24673389-992E73F6-8D77-4BAF-99FA-A7DAA41B3A1EQ24794092-D8BF3B5E-9A69-4144-A4CB-62C45EE6DB8CQ28646771-0C3B819E-298B-4158-B782-9F1B41D400CEQ28646874-DA94B33C-7E36-4144-B85F-C3FC802057F3Q28646881-7FE95330-CFC8-4DF6-B35B-DAB259200432Q29029627-1B950584-6B23-4DA7-93F1-56CB4B6AA991Q30278577-550B5EDC-BB74-40A6-A670-D853A7D37217Q30305454-1EEABA3E-6B83-416F-9E7F-7D0D631D103FQ30305455-840C3A19-53A6-495E-9AED-7BCE77716C96Q30448634-F90557A9-D2EC-428E-8753-E202CE13090AQ33328140-44103430-5EB9-4AD8-BC22-04703F7A70D8Q33575664-1CA97B50-7809-4131-AACA-F7D9C493A7E3Q33604871-9B3C451A-23D0-439C-A6C0-DAE7B359D1A4Q33627331-6D22E7A2-F71C-43AF-A00A-8D825024E0B5Q33641854-A763F5A4-90B7-4245-B466-547D725B88E0Q33645838-0F7E4B3C-2096-47D6-8C20-0454E2411B64Q33653627-7E6741C1-24F2-4515-A072-321DD3AB31A9Q33686847-C0647873-CEDB-4ED9-86FA-AED68045F8D2Q33707328-675663D2-13E8-4327-A231-70B804DFD7D7Q33719811-5E006FDF-705B-4CB7-9062-39175920CD71Q33750683-18425C18-A694-48C1-BF0F-735B5B2097B2Q33758570-0D268CD7-4989-4460-872C-FE100D813F3AQ33782045-3E17FCEA-ABD1-43B7-8580-A4F286D84DD1Q33782350-D10DB33C-4526-45DB-B377-7BC9BCD86F0DQ33783504-F2B8E018-FD79-4A28-849E-DE1E599305A3Q33784206-9418FFEA-2AF5-4351-ABD3-4FBF78CF3823Q33785490-93CBA6E1-0A88-4C8D-A529-82FDD15D1BD7Q33808640-88D7EAB6-AFB6-4C44-900D-EDDC49F17C4CQ33814773-53FBA1E5-085A-47DD-A67A-5FA629FC60E5Q33815193-A0B5532F-DA50-4CA3-86B3-8446EB754788Q33815285-06057F1F-9240-4A92-B2A7-3EFF19E00CE6Q33841640-8A3A5A53-EB3C-4A66-B2D9-B953285C7ED4Q33845055-A2C88362-B134-4A4F-A11E-0C56ACFB6E4BQ33847874-56B0EC7D-DF6F-4606-955A-B821B1549CC8Q33851598-837C4158-D265-4F10-9DE5-11FDF708BD38Q33979799-20CB051E-B375-44F8-B88C-66BF53AD57FB
P2860
Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Differential syncytium-inducin ...... IDS) and AIDS-related complex.
@en
type
label
Differential syncytium-inducin ...... IDS) and AIDS-related complex.
@en
prefLabel
Differential syncytium-inducin ...... IDS) and AIDS-related complex.
@en
P2093
P2860
P1433
P1476
Differential syncytium-inducin ...... IDS) and AIDS-related complex.
@en
P2093
Cuypers HT
Gruters RA
Huisman HG
Tersmette M
de Goede RE
P2860
P304
P407
P577
1988-06-01T00:00:00Z